Overview

An Investigational Study to Evaluate BMS-986165 in Participants With Systemic Lupus Erythematosus

Status:
Active, not recruiting
Trial end date:
2021-11-13
Target enrollment:
Participant gender:
Summary
This study will investigate BMS-986165 to assess its effects in participants with systemic lupus erythematosus (SLE).
Phase:
Phase 2
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
BMS-986165